Burden of severe neonatal jaundice: A systematic review and meta-analysis

Tina M. Slusher, Tara G. Zamora, Duke Appiah, Judith U. Stanke, Mark A. Strand, Burton W. Lee, Shane B. Richardson, Elizabeth M. Keating, Ashajoythi M. Siddappa, Bolajoko O. Olusanya

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

context To assess the global burden of late and/or poor management of severe neonatal jaundice (SNJ), a common problem worldwide, which May result in death or irreversible brain damage with disabilities in survivors. Population-based data establishing the global burden of SNJ has not been previously reported. Objective Determine the burden of SNJ in all WHO regions, as defined by clinical jaundice associated with clinical outcomes including acute bilirubin encephalopathy/kernicterus and/or exchange transfusion (ET) and/or jaundice-related death. Data sources PubMed, Scopus and other health databases were searched, without language restrictions, from 1990 to 2017 for studies reporting the incidence of SNJ. study selection/data extraction Stratification was performed for WHO regions and results were pooled using random effects model and meta-regression. results Of 416 articles including at least one marker of SNJ, only 21 reported estimates from population-based studies, with 76% (16/21) of them conducted in high-income countries. The African region has the highest incidence of SNJ per 10 000 live births at 667.8 (95% CI 603.4 to 738.5), followed by Southeast Asian, Eastern Mediterranean, Western Pacific, Americas and European regions at 251.3 (132.0 to 473.2), 165.7 (114.6 to 238.9), 9.4 (0.1 to 755.9), 4.4 (1.8 to 10.5) and 3.7 (1.7 to 8.0), respectively. The incidence of ET per 10 000 live births was significantly higher for Africa and Southeast Asian regions at 186.5 (153.2 to 226.8) and 107.1 (102.0 to 112.5) and lower in Eastern Mediterranean (17.8 (5.7 to 54.9)), Americas (0.38 (0.21 to 0.67)), European (0.35 (0.20 to 0.60)) and Western Pacific regions (0.19 (0.12 to 0.31). Only 2 studies provided estimates of clear jaundice-related deaths in infants with significant jaundice [UK (2.8%) and India (30.8%). conclusions Limited but compelling evidence demonstrates that SNJ is associated with a significant health burden especially in low-income and middle-income countries.

Original languageEnglish (US)
Article numberY
JournalBMJ Paediatrics Open
Volume1
Issue number1
DOIs
StatePublished - Dec 2017

Fingerprint

Neonatal Jaundice
Meta-Analysis
Jaundice
Kernicterus
Live Birth
Information Storage and Retrieval
Incidence
Health
PubMed
Population
Survivors
India
Cohort Studies
Language
Databases
Brain

Cite this

Slusher, T. M., Zamora, T. G., Appiah, D., Stanke, J. U., Strand, M. A., Lee, B. W., ... Olusanya, B. O. (2017). Burden of severe neonatal jaundice: A systematic review and meta-analysis. BMJ Paediatrics Open, 1(1), [Y]. https://doi.org/10.1136/bmjpo-2017-000105

Burden of severe neonatal jaundice : A systematic review and meta-analysis. / Slusher, Tina M.; Zamora, Tara G.; Appiah, Duke; Stanke, Judith U.; Strand, Mark A.; Lee, Burton W.; Richardson, Shane B.; Keating, Elizabeth M.; Siddappa, Ashajoythi M.; Olusanya, Bolajoko O.

In: BMJ Paediatrics Open, Vol. 1, No. 1, Y, 12.2017.

Research output: Contribution to journalArticle

Slusher, TM, Zamora, TG, Appiah, D, Stanke, JU, Strand, MA, Lee, BW, Richardson, SB, Keating, EM, Siddappa, AM & Olusanya, BO 2017, 'Burden of severe neonatal jaundice: A systematic review and meta-analysis', BMJ Paediatrics Open, vol. 1, no. 1, Y. https://doi.org/10.1136/bmjpo-2017-000105
Slusher, Tina M. ; Zamora, Tara G. ; Appiah, Duke ; Stanke, Judith U. ; Strand, Mark A. ; Lee, Burton W. ; Richardson, Shane B. ; Keating, Elizabeth M. ; Siddappa, Ashajoythi M. ; Olusanya, Bolajoko O. / Burden of severe neonatal jaundice : A systematic review and meta-analysis. In: BMJ Paediatrics Open. 2017 ; Vol. 1, No. 1.
@article{a8f9f50f702a4642a4913840239b7633,
title = "Burden of severe neonatal jaundice: A systematic review and meta-analysis",
abstract = "context To assess the global burden of late and/or poor management of severe neonatal jaundice (SNJ), a common problem worldwide, which May result in death or irreversible brain damage with disabilities in survivors. Population-based data establishing the global burden of SNJ has not been previously reported. Objective Determine the burden of SNJ in all WHO regions, as defined by clinical jaundice associated with clinical outcomes including acute bilirubin encephalopathy/kernicterus and/or exchange transfusion (ET) and/or jaundice-related death. Data sources PubMed, Scopus and other health databases were searched, without language restrictions, from 1990 to 2017 for studies reporting the incidence of SNJ. study selection/data extraction Stratification was performed for WHO regions and results were pooled using random effects model and meta-regression. results Of 416 articles including at least one marker of SNJ, only 21 reported estimates from population-based studies, with 76{\%} (16/21) of them conducted in high-income countries. The African region has the highest incidence of SNJ per 10 000 live births at 667.8 (95{\%} CI 603.4 to 738.5), followed by Southeast Asian, Eastern Mediterranean, Western Pacific, Americas and European regions at 251.3 (132.0 to 473.2), 165.7 (114.6 to 238.9), 9.4 (0.1 to 755.9), 4.4 (1.8 to 10.5) and 3.7 (1.7 to 8.0), respectively. The incidence of ET per 10 000 live births was significantly higher for Africa and Southeast Asian regions at 186.5 (153.2 to 226.8) and 107.1 (102.0 to 112.5) and lower in Eastern Mediterranean (17.8 (5.7 to 54.9)), Americas (0.38 (0.21 to 0.67)), European (0.35 (0.20 to 0.60)) and Western Pacific regions (0.19 (0.12 to 0.31). Only 2 studies provided estimates of clear jaundice-related deaths in infants with significant jaundice [UK (2.8{\%}) and India (30.8{\%}). conclusions Limited but compelling evidence demonstrates that SNJ is associated with a significant health burden especially in low-income and middle-income countries.",
author = "Slusher, {Tina M.} and Zamora, {Tara G.} and Duke Appiah and Stanke, {Judith U.} and Strand, {Mark A.} and Lee, {Burton W.} and Richardson, {Shane B.} and Keating, {Elizabeth M.} and Siddappa, {Ashajoythi M.} and Olusanya, {Bolajoko O.}",
year = "2017",
month = "12",
doi = "10.1136/bmjpo-2017-000105",
language = "English (US)",
volume = "1",
journal = "BMJ Paediatrics Open",
issn = "2399-9772",
number = "1",

}

TY - JOUR

T1 - Burden of severe neonatal jaundice

T2 - A systematic review and meta-analysis

AU - Slusher, Tina M.

AU - Zamora, Tara G.

AU - Appiah, Duke

AU - Stanke, Judith U.

AU - Strand, Mark A.

AU - Lee, Burton W.

AU - Richardson, Shane B.

AU - Keating, Elizabeth M.

AU - Siddappa, Ashajoythi M.

AU - Olusanya, Bolajoko O.

PY - 2017/12

Y1 - 2017/12

N2 - context To assess the global burden of late and/or poor management of severe neonatal jaundice (SNJ), a common problem worldwide, which May result in death or irreversible brain damage with disabilities in survivors. Population-based data establishing the global burden of SNJ has not been previously reported. Objective Determine the burden of SNJ in all WHO regions, as defined by clinical jaundice associated with clinical outcomes including acute bilirubin encephalopathy/kernicterus and/or exchange transfusion (ET) and/or jaundice-related death. Data sources PubMed, Scopus and other health databases were searched, without language restrictions, from 1990 to 2017 for studies reporting the incidence of SNJ. study selection/data extraction Stratification was performed for WHO regions and results were pooled using random effects model and meta-regression. results Of 416 articles including at least one marker of SNJ, only 21 reported estimates from population-based studies, with 76% (16/21) of them conducted in high-income countries. The African region has the highest incidence of SNJ per 10 000 live births at 667.8 (95% CI 603.4 to 738.5), followed by Southeast Asian, Eastern Mediterranean, Western Pacific, Americas and European regions at 251.3 (132.0 to 473.2), 165.7 (114.6 to 238.9), 9.4 (0.1 to 755.9), 4.4 (1.8 to 10.5) and 3.7 (1.7 to 8.0), respectively. The incidence of ET per 10 000 live births was significantly higher for Africa and Southeast Asian regions at 186.5 (153.2 to 226.8) and 107.1 (102.0 to 112.5) and lower in Eastern Mediterranean (17.8 (5.7 to 54.9)), Americas (0.38 (0.21 to 0.67)), European (0.35 (0.20 to 0.60)) and Western Pacific regions (0.19 (0.12 to 0.31). Only 2 studies provided estimates of clear jaundice-related deaths in infants with significant jaundice [UK (2.8%) and India (30.8%). conclusions Limited but compelling evidence demonstrates that SNJ is associated with a significant health burden especially in low-income and middle-income countries.

AB - context To assess the global burden of late and/or poor management of severe neonatal jaundice (SNJ), a common problem worldwide, which May result in death or irreversible brain damage with disabilities in survivors. Population-based data establishing the global burden of SNJ has not been previously reported. Objective Determine the burden of SNJ in all WHO regions, as defined by clinical jaundice associated with clinical outcomes including acute bilirubin encephalopathy/kernicterus and/or exchange transfusion (ET) and/or jaundice-related death. Data sources PubMed, Scopus and other health databases were searched, without language restrictions, from 1990 to 2017 for studies reporting the incidence of SNJ. study selection/data extraction Stratification was performed for WHO regions and results were pooled using random effects model and meta-regression. results Of 416 articles including at least one marker of SNJ, only 21 reported estimates from population-based studies, with 76% (16/21) of them conducted in high-income countries. The African region has the highest incidence of SNJ per 10 000 live births at 667.8 (95% CI 603.4 to 738.5), followed by Southeast Asian, Eastern Mediterranean, Western Pacific, Americas and European regions at 251.3 (132.0 to 473.2), 165.7 (114.6 to 238.9), 9.4 (0.1 to 755.9), 4.4 (1.8 to 10.5) and 3.7 (1.7 to 8.0), respectively. The incidence of ET per 10 000 live births was significantly higher for Africa and Southeast Asian regions at 186.5 (153.2 to 226.8) and 107.1 (102.0 to 112.5) and lower in Eastern Mediterranean (17.8 (5.7 to 54.9)), Americas (0.38 (0.21 to 0.67)), European (0.35 (0.20 to 0.60)) and Western Pacific regions (0.19 (0.12 to 0.31). Only 2 studies provided estimates of clear jaundice-related deaths in infants with significant jaundice [UK (2.8%) and India (30.8%). conclusions Limited but compelling evidence demonstrates that SNJ is associated with a significant health burden especially in low-income and middle-income countries.

UR - http://www.scopus.com/inward/record.url?scp=85048248682&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048248682&partnerID=8YFLogxK

U2 - 10.1136/bmjpo-2017-000105

DO - 10.1136/bmjpo-2017-000105

M3 - Article

AN - SCOPUS:85048248682

VL - 1

JO - BMJ Paediatrics Open

JF - BMJ Paediatrics Open

SN - 2399-9772

IS - 1

M1 - Y

ER -